Publications by authors named "Michael Cobble"

Claim this Profile
C
Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.
Zareen M Farukhi, Olga V Demler, Michael P Caulfield, Krishnaji Kulkarni, Jay Wohlgemuth, Michael Cobble

J Clin Lipidol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Studies in Hyperlipidemia.
Michael Cobble

J Fam Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment.
Heike Luttmann-Gibson, Samia Mora, Carlos A Camargo, Nancy R Cook, Olga V Demler, Michael Cobble

Contemp Clin Trials· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class effects of SGLT2 inhibitors on cardiorenal outcomes.
Aaron Y Kluger, Kristen M Tecson, Andy Y Lee, Edgar V Lerma, Janani Rangaswami, Michael E Cobble

Cardiovasc Diabetol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualizing Treatment with Statin Therapy.
Harold E Bays, Michael Cobble

J Fam Pract· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review.
Aaron Y Kluger, Kristen M Tecson, Clay M Barbin, Andy Y Lee, Edgar V Lerma, Michael E Cobble

Rev Cardiovasc Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women.
Paulo H N Harada, Julie E Buring, Nancy R Cook, Michael E Cobble, Krishnaji R Kulkarni

J Endocr Soc· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertriglyceridemia: the importance of identifying patients at risk.
Pamela A Kushner, Michael E Cobble

Postgrad Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary heart disease in women.
Michael Cobble

J Fam Pract· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers.
Elaine Chiquette, Peter P Toth, Gilbert Ramirez, Michael Cobble, Robert Chilton

Vasc Health Risk Manag· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
Michael E Cobble

Am J Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary heart disease in men.
Michael E Cobble

J Fam Pract· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus.
Michael Cobble

Diabetol Metab Syndr· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data.
Michael E Cobble, Robert Frederich

Cardiovasc Diabetol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.
Kenneth J Colley, Robert L Wolfert, Michael E Cobble

EPMA J· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing among incretin-based therapies. Glucose-lowering effects of incretin-based therapies.
R Keith Campbell, Michael E Cobble, Timothy S Reid, Mansur E Shomali

J Fam Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies.
R Keith Campbell, Michael E Cobble, Timothy S Reid, Mansur E Shomali

J Fam Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing among incretin-based therapies. Patient education and self-management.
R Keith Campbell, Michael E Cobble, Timothy S Reid, Mansur E Shomali

J Fam Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing among incretin-based therapies. Introduction.
R Keith Campbell, Michael E Cobble, Timothy S Reid, Mansur E Shomali

J Fam Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies.
R Keith Campbell, Michael E Cobble, Timothy S Reid, Mansur E Shomali

J Fam Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carotid intima-media thickness: knowledge and application to everyday practice.
Michael Cobble, Bradley Bale

Postgrad Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?
Michael E Cobble, Anne L Peters

J Fam Pract· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to implement incretin therapy.
Michael E Cobble

J Fam Pract· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis